GEVA

Synageva BioPharma Corp. News Headlines

$75.74
*  
4.32
5.4%
Get GEVA Alerts
*Delayed - data as of Oct. 31, 2014  -  Find a broker to begin trading GEVA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GEVA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
TKMR Stays Focused On Ebola, GEVA Sets Work Rolling, FDA Panel Nod For VRTX
10/22/2014 12:24:00 AM - RTT News


3 Big-Volume Stocks to Trade for Breakouts
10/16/2014 9:26:00 AM - TheStreet


Synageva''s Sebelipase Alfa Phase 3 Data Selected For Oral Presentation
10/8/2014 10:29:00 AM - RTT News


Synageva Slips on Wider-than-Expected Q2 Loss - Analyst Blog
8/1/2014 4:30:00 PM - Zacks.com


Thursday's ETF Movers: BSCF, XBI
7/31/2014 1:38:01 PM - BNK Invest


Sector Update: Health Care
7/18/2014 1:33:31 PM - MT Newswires


Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 10% After Naming Cancer-Specialist to Board
7/18/2014 1:32:37 PM - MT Newswires


Synageva's Sebelipase Alfa Meets Primary Endpoint in ARISE - Analyst Blog
7/1/2014 4:00:00 PM - Zacks.com


Synageva's Q1 Loss Narrower than Expected - Analyst Blog
5/1/2014 5:10:01 PM - Zacks.com


Synageva Heading For Big Disappointment
4/22/2014 11:05:00 AM - Seeking Alpha


Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - Seeking Alpha


Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - SeekingAlpha


Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog
3/4/2014 12:00:01 PM - Zacks.com


After-Hours Earnings Report for March 3, 2014 : SCTY, VIPS, GWRE, GEVA, URS, MR, ASNA, MDR, NUVA, DXPE, MCP, AUQ
3/3/2014 3:00:01 PM - NASDAQ.com News


Synageva BioPharma Corp. (GEVA) in Focus: Stock Moves 5.1% Higher - Tale of the Tape
2/20/2014 10:21:01 AM - Zacks.com


Will Synageva (GEVA) Continue to Surge Higher? - Tale of the Tape
1/29/2014 8:27:01 AM - Zacks.com


Patients Enrolled in Synageva Study - Analyst Blog
1/7/2014 5:15:01 PM - Zacks.com


Orphan Drug Designations: Why You Should Care
12/12/2013 10:23:00 AM - Seeking Alpha


Synageva Progresses with Sebelipase Alpha - Analyst Blog
12/4/2013 12:06:23 PM - Zacks.com


Synageva: A Strong Candidate For Your Portfolio
10/8/2013 2:01:00 PM - Seeking Alpha


Synageva Raises Funds - Analyst Blog
10/1/2013 5:47:36 PM - Zacks.com


Insiders at Synageva BioPharma and Bind Therapeutics Buy Shares
9/30/2013 10:12:00 AM - Minyanville


Synageva Prices Public Offering - Analyst Blog
9/25/2013 5:05:01 PM - Zacks.com


Sector Update: Healthcare Stocks Flat in Pre-Market; Syngeva Prices Public Offering
9/25/2013 8:00:52 AM - MT Newswires


Sector Update: Healthcare
9/25/2013 8:00:05 AM - MT Newswires